New targeted therapies in breast cancer

被引：37

作者：

Kaklamani, V

O'Regan, RM

机构：

[1] Emory Univ, Winship Canc Inst, Translat Breast Canc Res Program, Atlanta, GA 30322 USA

[2] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA

[3] Northwestern Univ, Div Hematol Oncol, Chicago, IL USA

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 02期

关键词：

D O I：

10.1053/j.seminoncol.2004.02.018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：20 / 25

页数：6

共 34 条

[1]

Abe O, 1998, LANCET, V352, P930

[2]

Albain K, 2002, BREAST CANCER RES TR, V76, pS33

[3] Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer [J].

Allen, LF ;

Lenehan, PF ;

Eiseman, IA ;

Elliott, WL ;

Fry, DW .

SEMINARS IN ONCOLOGY, 2002, 29 (03) :11-21

[4] HEAT REPEATS IN THE HUNTINGTONS-DISEASE PROTEIN [J].

ANDRADE, MA ;

BORK, P .

NATURE GENETICS, 1995, 11 (02) :115-116

[5]

[Anonymous], P AM SOC CLIN ONCOL

[6] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].

Baselga, J ;

Tripathy, D ;

Mendelsohn, J ;

Baughman, S ;

Benz, CC ;

Dantis, L ;

Sklarin, NT ;

Seidman, AD ;

Hudis, CA ;

Moore, J ;

Rosen, PP ;

Twaddell, T ;

Henderson, IC ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744

[7]

BASELGA J, 2003, P AN M AM SOC CLIN, V22, P7

[8] ESTROGEN-DEPENDENT, TAMOXIFEN-RESISTANT TUMORIGENIC GROWTH OF MCF-7 CELLS TRANSFECTED WITH HER2/NEU [J].

BENZ, CC ;

SCOTT, GK ;

SARUP, JC ;

JOHNSON, RM ;

TRIPATHY, D ;

CORONADO, E ;

SHEPARD, HM ;

OSBORNE, CK .

BREAST CANCER RESEARCH AND TREATMENT, 1992, 24 (02) :85-95

[9] Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: Multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm [J].

Burstein, HJ ;

Harris, LN ;

Marcom, PK ;

Lambert-Falls, R ;

Havlin, K ;

Overmoyer, B ;

Friedlander, RJ ;

Gargiulo, J ;

Strenger, R ;

Vogel, CL ;

Ryan, PD ;

Ellis, MJ ;

Nunes, RA ;

Bunnell, CA ;

Campos, SM ;

Hallor, M ;

Gelman, R ;

Winer, EP .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2889-2895

[10]

Chan S, 2002, BREAST CANCER RES TR, V76, pS132

← 1 2 3 4 →